JC virus granule cell neuronopathy associated with Ruxolitinib: A case report and review of the literature

JC virus granule cell neuronopathy associated with Ruxolitinib: A case report and review of the literature

Bibliographic Details
Main Authors:	Kentaro Nakayama, Masataka Nakamura, Akiko Konishi, Satoshi Kaneko, Kazuo Nakamichi, Masayuki Saijo, Yusuke Yakushiji, Hirofumi Kusaka
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	eNeurologicalSci
Subjects:	Progressive multifocal leukoencephalopathy Granule cell neuronopthy JC virus Myelofibrosis Ruxolitinib
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405650220300484

Similar Items

A fulminant case of JC virus encephalopathy supporting a novel syndrome associated with JC virus infection of cortical neurons
by: Matteo Ciocca, et al.
Published: (2016-07-01)

Improving detection of JC virus by ultrafiltration of cerebrospinal fluid before polymerase chain reaction for the diagnosis of progressive multifocal leukoencephalopathy
by: Kazuo Nakamichi, et al.
Published: (2019-10-01)

Tuberculosis in Patients with Primary Myelofibrosis During Ruxolitinib Therapy: Case Series and Literature Review
by: Peng Y, et al.
Published: (2020-09-01)

JC Polyomavirus and Transplantation: Implications for Virus Reactivation after Immunosuppression in Transplant Patients and the Occurrence of PML Disease
by: James E. K. Hildreth, et al.
Published: (2021-02-01)

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system
by: Vincenzo Accurso, et al.
Published: (2019-03-01)

JC virus granule cell neuronopathy onset two months after chemotherapy for low-grade lymphoma
by: Kathryn B. Holroyd, et al.
Published: (2017-06-01)

Reactivation of tuberculosis following ruxolitinib therapy for primary myelofibrosis: Case series and literature review
by: Farhan Khalid, et al.
Published: (2021-09-01)

Beyond Ruxolitinib: Fedratinib and Other Emergent Treatment Options for Myelofibrosis
by: Bewersdorf JP, et al.
Published: (2019-12-01)

Ruxolitinib for treatment of polycythemia vera and myelofibrosis in patients after liver transplantation
by: Leona Dold, et al.
Published: (2021-09-01)

Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis
by: M. S. Fominykh, et al.
Published: (2016-08-01)

The absence of JC virus antigens in Indian children with medulloblastomas
by: Vasishta Rakesh, et al.
Published: (2009-01-01)

Application of inhibitor JAK1 and JAK2 ruxolitinib as pre- and posttransplant therapy in patients with myelofibrosis
by: M. V. Barabanshchikova, et al.
Published: (2016-03-01)

Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses
by: Srdan Verstovsek, et al.
Published: (2017-09-01)

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
by: E.C. Rosca, et al.
Published: (2008-12-01)

Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
by: Hans Michael Kvasnicka, et al.
Published: (2018-03-01)

Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan
by: Nakamichi Kazuo, et al.
Published: (2012-10-01)

Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review
by: Naruemit Sayabovorn, et al.
Published: (2021-01-01)

JC virus-associated central nervous system diseases in HIV-infected patients in Brazil: clinical presentations, associated factors with mortality and outcome
by: Felipe Piza, et al.

Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib
by: Bugra Kerget, et al.
Published: (2017-01-01)

Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions
by: Abigail L. Atkinson, et al.
Published: (2020-09-01)

Evaluation of an alternative ruxolitinib dosing regimen in patients with myelofibrosis: an open-label phase 2 study
by: Moshe Talpaz, et al.
Published: (2018-08-01)

Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis
by: Novella Pugliese, et al.
Published: (2019-06-01)

Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosis
by: Anna Hirano, et al.
Published: (2017-01-01)

Progressive multifocal leukoencephalopathy associated with thymoma with immunodeficiency: a case report and literature review
by: Tatsuya Ueno, et al.
Published: (2018-04-01)

Distribuição genotípica do poliomavirus humano JC em pacientes com aids, com e sem leucoencefalopatia multifocal progressiva, em São Paulo, Brasil
by: Maria Cristina Domingues da Silva Fink
Published: (2010)

Distribuição genotípica do poliomavirus humano JC em pacientes com aids, com e sem leucoencefalopatia multifocal progressiva, em São Paulo, Brasil
by: Fink, Maria Cristina Domingues da Silva
Published: (2010)

Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod
by: Mitsuru Watanabe, et al.
Published: (2020-07-01)

Disseminated tuberculosis in a patient treated with a JAK2 selective inhibitor: a case report
by: Colomba Claudia, et al.
Published: (2012-10-01)

A case of progressive multifocal leukoencephalopathy in a HIV-infected female patient
by: E A Samotolkina, et al.
Published: (2016-11-01)

Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis
by: Luciana Prats Branco, et al.

Progressive multifocal leukoencephalopathy in non-HIV patient
by: Diego Rosseman Vieira, et al.

A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis
by: Stephen Couban, et al.
Published: (2018-09-01)

Leucoencefalopatia multifocal progressiva confirmada por PCR para vírus JC no líquor: relato de caso Progressive multifocal leukoencephalopathy confirmed by PCR: case report
by: Alessandro Comarú Pasqualotto, et al.
Published: (2004-06-01)

Smoldering myeloma presenting as progressive multifocal leukoencephalopathy: a case report
by: Troppmann Martina, et al.
Published: (2012-07-01)

Progressive Multifocal Leukoencephalopathy in a HIV-Negative Patient with Small Lymphocytic Leukemia following Treatment with Rituximab
by: Subhankar Chakraborty, et al.
Published: (2011-03-01)

The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms
by: Graeme Greenfield, et al.
Published: (2018-12-01)

Combined Pulmonary Tuberculosis with Pulmonary and Pleural Cryptococcosis in a Patient Receiving Ruxolitinib Therapy
by: Kasemchaiyanun A, et al.
Published: (2021-09-01)

Progressive multifocal leukoencephalopathy: a challenging diagnosis established at autopsy
by: Cesar Castello Branco Lopes, et al.
Published: (2019-08-01)

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient
by: Krisztina K. Johansen, et al.
Published: (2013-09-01)

B Cells and Progressive Multifocal Leukoencephalopathy: Search for the Missing Link
by: Deniz eDurali, et al.
Published: (2015-05-01)